AI4Eyes Joins MEDTEQ+ Avise Program with $700,000 Grant for Clinical Validation
Jul 07, 2026
Funding
Haut.AI Launches Clinical Studies Software for Skin Research
August 04, 2026
Haut.AI has launched Clinical Studies Software for remote, hybrid, and clinic based skin studies. The platform measures 48 skin biomarkers with AI and supports studies with hundreds or thousands of participants.
Haut.AI has launched Clinical Studies Software, a platform for remote, hybrid, and clinic based skin studies, the company announced in a press release. The software is designed for skincare, beauty, ingredient, and dermatology companies running studies across participant groups of hundreds to thousands.
The platform uses standardized image capture and AI based measurement to quantify 48 validated biomarkers, including wrinkles, pigmentation, texture, acne, redness, and pore appearance. Researchers can collect images in clinics or remotely through Haut.AI's LIQA technology, then view cohort analytics, longitudinal tracking, phenotype segmentation, and efficacy measurements in a dashboard.
The company said study setup can move from a typical 8 to 16 weeks to two or three days. The platform also generates reports and visual evidence packages for product claims.
The software is built on AI models developed with dermatologists and evaluated at Institut d'Expertise Clinique against a consensus panel of expert graders. Validation showed ICC 0.97 to 0.98 repeatability across five facial skin endpoints.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
08/04
Captello Launches Healthcare Database for Provider Lead Enrichment
08/03
Parlance Adds Instant Voice Agent Settings and AI Call Summaries
08/03
Invenio Imaging Completes Enrollment in AI Lung Cancer Biopsy Study
08/03
Genprex and Roche Diagnostics to Validate TROP2 Biomarker Assays for Lung Cancer Trials
08/03
Signant Health Launches Forecasting & Planning Assist for Clinical Supplies
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more